PREVENT [phsu]
Osteoporosis, Post-Menopausal [dsyn]
Update [tmco]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulators [horm, phsu]
Class [inpr]
Compound [qlco]
Safeties [hcpp]
TOLERABILITY [resa]
Therapies [topp]
postmenopausal [tmco]
Women [popg]
Multifactorial [fndg]
Nature [idcn]
Estrogen [horm, phsu, strd]
Regulation [gora]
Good [qlco]
Basis [ftcn]
Mechanism [ftcn]
SERM [horm, phsu]
actions [ftcn]
Extensive [qlco]
preclinical studies [resa]
effects [qlco]
Raloxifene [orch, phsu]
Skeleton [bdsy]
Well [qlco]
Documented [hlca]
Complete [qlco]
Estrogen Effects [fndg]
Antagonist [ortf]
Raloxifene [orch, phsu]
Uterine [bpoc]
Mammary [bpoc]
Tissues [tisu]
Cardiovascular disease [dsyn]
Leading [tmco]
Mortality [qnco]
postmenopausal [tmco]
Women [popg]
Raloxifene [orch, phsu]
CARDIOVASCULAR [bdsy]
Great [qnco]
Interest [menp]
Clinical Data [inpr]
effects [qlco]
Raloxifene [orch, phsu]
CARDIOVASCULAR [bdsy]
Not available [idcn]
Raloxifene [orch, phsu]
Heart [bpoc]
Trial [resa]
randomized [resa]
CARDIOVASCULAR [bdsy]
Study [mnob]
Initiate [idcn]
Area [geoa]
Interest [menp]
findings [ftcn]
Cognition [menp]
Enhance [acty]
effects [qlco]
Estrogen [horm, phsu, strd]
Focused attention [menp]
effects [qlco]
Estrogens [horm, phsu, strd]
Selective Estrogen Receptor Modulators [horm, phsu]
Brain [bpoc]
Available [ftcn]
Pre-clinical [qlco]
Clinical Data [inpr]
Raloxifene [orch, phsu]
Suggest [idcn]
promise [idcn]
risk benefit [qlco]
Profile [lbpr]
Continue [idcn]
Compound [qlco]
Complex [qlco]
Mechanism [ftcn]
Action [ftcn]
Safety [hcpp]
Efficacy [qlco]
Science [ocdi]
Reserve [acty]
